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DObjective: Limited long-term outcome data are available on survival and the need for aortic root or valve re-
operation after surgery for acute ascending aorta dissection. We report our 42-year experience.
Methods:We reviewed the records of 269 patients who had undergone surgery for acute ascending aorta dissec-
tion from July 1969 to June 2011. The mean age at surgery was 62.1  15.2 years, and 181 were men (67.3%).
The distal operation was limited to hemiarch replacement. The proximal aortic operation groups included a com-
posite valve conduit in 66 patients (24.5%), aortic root repair in 112 (41.6%), and isolated supracoronary
ascending aorta replacement in 91 (33.8%).
Results: Operative morbidity occurred in 224 patients (83.3%) and mortality in 44 (16.4%), with similar rates
among the groups (P¼ .894 and P¼ .466, respectively). The mean follow-up was 9.7 7.5 years. The Kaplan-
Meier survival estimate at 10 and 20 years was 65.5% 3.6% and 28.7% 4.3%, respectively, and was similar
among the groups (P¼ .227). Reoperation on the aortic root or valve occurred in 20 patients (8.9%) at a median
of 6.8 years (range, 0.2-20.3). The freedom from reoperation rate at 10 and 20 years was 91.5%  2.3% and
79.3%  6.1%, respectively, with no difference among the groups (P ¼ .605).
Conclusions:Operativemorbidity and mortality rates are significant after repair of acute ascending aorta dissec-
tion. Aortic root surgery can be performed without an apparent increase in the prevalence of operative morbidity
or mortality; however, patients remain at risk of subsequent aortic root or valve surgery. (J Thorac Cardiovasc
Surg 2014;148:2117-22)See related commentary on pages 2123-4.Surgery for acute ascending aorta dissection may result in
significant morbidity and mortality rates.1 The main goals
of surgery are to prevent death of the patient from aortic
rupture, to correct malperfusion and restore blood flow in
the true aortic lumen, and to correct aortic valvular regurgi-
tation. Achieving these goals requires varying degrees of
operation on the aortic root, the long-term outcomes of
which have not been extensively studied. To address this
issue, we reviewed our single-center, 42-year experience
in the management of acute ascending aortic dissection.
We report the outcomes of long-term survival and freedom
from subsequent aortic root or valve surgery stratified by
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The institutional review board approved the present study, and all the
patients or their families gave informed consent. We reviewed the records
of all patients who had undergone surgery for acute ascending aorta dissec-
tion from July 1969 to June 2011 at Mayo Clinic (Rochester, Minn). We
identified 400 patients, and eliminated 131 who had 1 of the following:
previous cardiac surgery (n ¼ 79), aortic arch replacement (n ¼ 13), iatro-
genic aortic dissection (n¼ 27), insufficient data (n¼ 8), or primary repair
of the ascending aorta (n ¼ 8).
We reviewed the medical records of 269 patients and collected data
related to patient characteristics, surgery, and follow-up. All patients
had undergone replacement of the supracoronary ascending aorta with
a polyester graft. The distal extent of the operation was limited to a
hemiarch replacement. We recorded the postoperative complications
as defined using the Society of Thoracic Surgeons criteria and acute
kidney injury as defined by the Acute Kidney Injury Network criteria.2
For the purposes of the present study, we divided the patients into 3
groups according to the type of procedure performed on the aortic root.
The operations included composite valve conduit placement in 66 patients
(24.5%), aortic root repair (eg, aortic valve commissure suspension, recon-
struction or replacement of a sinus of Valsalva) in 112 patients (41.6%),
and isolated supracoronary ascending aorta replacement in 91 patients
(33.8%). The primary endpoint of the study was survival, with a secondary
endpoint of freedom from reoperation on the aortic root or valve.
We report the categorical data as numbers and frequencies and contin-
uous data as the mean standard deviation andmedian and range. Many of
the study variables occurred with low numbers and did not lend themselves
to reliable statistical analysis. Recognizing this limitation, where appro-
priate, we analyzed the categorical data using the Fisher exact test or
chi-square test and continuous data using the nonparametric rank sum test.
We had follow-up data for all the patients and performed logistic regres-
sion analysis to determine the univariate and multivariate predictors of
outcome. We constructed survival and freedom from reoperation curvesdiovascular Surgery c Volume 148, Number 5 2117
TABLE 1. Patient characteristics
Variable
Composite valve conduit
group (n ¼ 66)
Root repair group
(n ¼ 112)
Isolated supracoronary ascending
aorta replacement (n ¼ 91)
Continuous
Age (y)
Mean  SD 53.4  16.6 64.7  13.74 65.2  13.5
Median 54.7 65.9 67.7
Range 17.9-88.9 18.6-88.2 23.7-89.3
Body surface area (m2)
Mean  SD 2.0  0.2 1.9  0.3 1.9  0.3
Median 2.0 2.0 1.9
Range 1.5-2.8 1.3-2.8 1.4-2.5
Creatinine (mg/dL)
Mean  SD 1.1  0.4 1.5  1.7 1.3  1.0
Median 1.1 1.2 1.1
Range 0.5-2.5 0.5-14.6 0.6-9.9
Categorical
Male sex 49 (74.2) 79 (70.5) 53 (58.2)
Diabetes (oral agent or insulin) 1 (1.5) 5 (4.4) 0
Hypertension 27 (40.9) 73 (65.2) 70 (76.9)
Chronic lung disease (moderate or severe) 2 (3.0) 4 (3.5) 2 (2.2)
Peripheral vascular disease 8 (12.1) 13 (11.6) 11 (12.1)
Cerebrovascular disease 7 (10.6) 10 (8.9) 7 (7.7)
Connective tissue disorder 4 (6.1) 1 (0.9) 3 (3.3)
NYHA functional class (III or IV) 32 (48.5) 28 (24.8) 25 (27.5)
Cardiogenic shock 4 (6.1) 14 (12.4) 7 (7.7)
Cardiopulmonary resuscitation 0 7 (6.2) 2 (2.2)
Aortic valve stenosis (moderate or severe) 3 (4.5) 1 (0.9) 3 (3.3)
Aortic valve regurgitation (moderate or severe) 59 (89.4) 57 (50.4) 11 (12.1)
Data presented as n (%), unless otherwise noted. SD, Standard deviation; NYHA, New York Heart Association.
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test. All statistical tests were 2-sided.
The demographic data of the 269 patients included amean age of 62.1
15.2 years (median, 64.9; range, 17.9-89.3), male sex in 181 patients
(67.3%), and the presence of hypertension in 170 (63.2%). Moderate or
severe aortic valve regurgitation was present in 127 patients (47.7%) and
was more common in patients who had undergone composite valve conduit
placement (59 patients, 90.8%) or root repair (57 patients, 51.4%) than in
those who had undergone isolated supracoronary artery aorta replacement
(11 patients, 12.2%; P< .001). The patient characteristics stratified by
group assignment are listed in Table 1.
RESULTS
An open distal aortic anastomosis was done in 166 pa-
tients (61.7%) and included hemiarch replacement in 123
patients (45.7%). Aortic valve replacement was performed
in 81 patients (30.1%) and included 66 patients (100%) in
the composite valve conduit group, 4 (4.9%) in the root
repair group, and 11 (12.1%) in the isolated supracoronary
ascending aorta replacement group. The valve replacement
was mechanical in 63 patients (77.8%), biologic in 16
(19.8%), and a homograft in 2 (2.5%). In the composite
valve conduit group, the replacement was mechanical in
53 patients (80.3%), biologic in 11 (16.7%; 10 were
porcine stentless conduits), and a homograft in 2 (3.0%).
Aortic valve repair included aortic valve commissural
suspension in 86 patients (76.8%) in the root repair group2118 The Journal of Thoracic and Cardiovascular Surand 0 patients in the isolated supracoronary ascending aorta
replacement group. Aortic valve-sparing procedures were
done in 6 patients (5.4%) in the root repair group: reimplan-
tation in 4 and remodeling in 2. The operative data,
including each group’s operative time, cardiopulmonary
bypass time, aortic crossclamp time, and circulatory arrest
time, are listed in Table 2.
Concomitant operative procedures were done in 66 pa-
tients (24.4%). These procedures included coronary artery
bypass grafting in 44 patients, vascular procedures in 12,
and other procedures in 10 patients. The other procedures
included repair of the pulmonary artery in 4, mitral or
tricuspid valve procedure in 3, septalmyectomy in 1, closure
of a patent foramen ovale in 1, and thymectomy in 1.
All patients received a red blood cell transfusion. The
transfusion included 14  10 units (median, 11; range, 2-
56) of packed red blood cells in the composite valve conduit
group, 13  8 units (median, 11; range, 3-45) in the root
repair group, and 13  12 units (median, 9.5; range, 3-87)
in the isolated supracoronary ascending aorta replacement
group. No significant difference was found in the red blood
cell transfusion amount among the groups (P ¼ .293).
Furthermore, no difference was found in the transfusion
amount of fresh frozen plasma (P ¼ .056), cryoprecipitate
(P ¼ .054), or platelets (P ¼ .098).gery c November 2014
TABLE 2. Operative procedure data
Variable
Composite valve conduit
group (n ¼ 66)
Root repair group
(n ¼ 112)
Isolated supracoronary ascending
aorta replacement group (n ¼ 91)
Continuous
Operative time (min)
Mean  SD 359.4  101.5 327.9  81.6 306.8  99.0
Median 337.5 320 279.5
Range 210-623 177-562 170-680
Cardiopulmonary bypass time (min)
Mean  SD 178.0  59.5 150.4  53.9 139.6  58.0
Median 161.5 144.5 135
Range 89-354 55-458 40-348
Aortic crossclamp time (min)
Mean  SD 114.2  33.5 81.0  34.5 81.4  40.1
Median 107 76.5 73
Range 58-234 8-215 13-212
Circulatory arrest time (min)
Mean  SD 27.7  10.2 26.4  12.0 28.3  11.4
Median 25.5 25 27
Range 14-62 2-76 4-56
Categorical
Simple ascending aorta replacement 41 (62.1) 43 (38.4) 62 (68.1)
Hemiarch replacement 25 (37.9) 69 (61.6) 29 (31.9)
Open distal aortic anastomosis 29 (43.9) 91 (81.35) 46 (50.6)
Aortic valve replacement 66 (100) 4 (3.6) 11 (12.1)
Concomitant cardiac operation 17 (25.8) 27 (24.1) 23 (25.3)
Data presented as n (%), unless otherwise noted. SD, Standard deviation.
Wang et al Acquired Cardiovascular Disease
A
C
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including 54 (81.8%) in the composite valve group,
93 (83.0%) in the root repair group, and 77 (84.6%) in
the isolated supracoronary ascending aorta replacement
group (P ¼ .895; Table 3). The degree of aortic regurgita-
tion at presentation (P¼ .328) and the type of operative pro-
cedure (P ¼ .895) were not predictive of any complication.
The specific operative complications were pulmonary
related in 128 patients (47.9%), renal related in 118TABLE 3. Thirty-day or in-hospital outcome data
Variable
Composite valve conduit
group (n ¼ 66)
Complication (any) 54 (81.8)
Reoperation for bleeding 9 (13.6)
Delayed sternal closure 3 (4.6)
Myocardial infarction 1 (1.5)
Neurologic complication 13 (19.7)
Stroke 4 (6.3)
Pulmonary complication 27 (41.5)
Intubation>24 h 27 (41.5)
Renal complication 24 (36.9)
Stratified by AKIN classification
Stage 1 19 (29.2)
Stage 2 1 (1.5)
Stage 3 4 (6.2)
Mortality (30-d or in-hospital) 9 (13.6)
Data presented as n (%). AKIN, Acute Kidney Injury Network.
The Journal of Thoracic and Car(44.2%), and neurology related in 58 patients (21.6%).
No differences were found among the groups with respect
to the prevalence of pulmonary-related (P ¼ .313) or
renal-related (P ¼ .101) complications. Stroke occurred
in 4 patients (6.3%) in the composite valve conduit
group, 12 (10.7%) in the root repair group, and 5
(5.7%) in the isolated ascending aorta replacement
group, with no significant differences among the groups
(P ¼ .361).Root repair group
(n ¼ 112)
Isolated supracoronary ascending
aorta replacement group (n ¼ 91)
93 (83.0) 77 (84.6)
6 (5.5) 7 (7.8)
1 (0.9) 1 (1.1)
2 (1.8) 0
24 (21.4) 21 (23.1)
12 (10.7) 5 (5.7)
59 (52.7) 42 (46.7)
57 (50.9) 41 (45.6)
58 (51.8) 36 (40.0)
40 (35.7) 24 (26.7)
7 (6.3) 9 (10.0)
11 (9.8) 3 (3.3)
22 (19.6) 13 (14.3)
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FIGURE 1. Kaplan-Meier estimate survival curve.
TABLE 4. Predictors of late mortality
Predictors of late mortality HR 95% CI P value
Univariate
Aortic valve stenosis
(moderate or severe)
4.64 1.4-11.2 .016
Chronic lung disease 2.61 0.91-5.83 .070
Cerebrovascular disease 1.99 1.06-3.43 .033
Stroke 1.34 0.54-2.98 .544
Atrial fibrillation 1.06 0.63-1.70 .810
Age at surgery 1.04 1.02-1.05 <.001
Aortic valve regurgitation
(moderate or severe)
0.76 0.52-1.10 .147
Multivariate
Aortic valve stenosis 2.27 0.67-5.81 .170
Stroke 1.84 0.96-3.22 .064
Age at surgery 1.03 1.02-1.05 <.001
HR, Hazard ratio; CI, confidence interval.
FIGURE 2. Kaplan-Meier estimate for freedom from reoperation on the
aortic root or valve.
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44 patients (16.4%; Table 3). No differences were found
in the mortality rates among the groups (P¼ .466). Further-
more, the operative mortality rates did not differ by decade
of operation: 1969 to 1979, 4 of 22 (18.2%); 1980 to 1989,
12 of 68 (17.7%); 1990 to 1999, 8 of 60 (13.3%); and, 2000
to 2011, 20 of 119 (16.8%; P ¼ .907). We analyzed the pa-
tient characteristics by the decade of surgery and identified
a significant increase in the median age from the first (50.8
years; range, 18.6-77.5) to the last (67.2 years; range, 21.8-
88.9) decade (P ¼ .004).
The follow-up data were complete for all patients who
survived surgery. The average follow-up period was 9.7 
7.5 years (median, 7.7; range, 0.12-35.0). No difference
was found in the follow-up duration among the groups
(P ¼ .128). At the last follow-up visit, 114 patients
(42.2%) were alive, including 27 (40.9%) in the composite
valve group, 57 (50.9%) in the root repair group, and 30
(33.0%) in the isolated supracoronary ascending aorta
replacement group.
The survival rate for all patients at 10 and 20 years was
54.8%  3.4% and 24.0%  3.7%, respectively
(Figure 1). No difference was found in survival among the
groups (P ¼ .227). However, the patients with dissection
had a significant reduction in survival compared with age-
and gender-matched controls (P< .001). The significant
predictors of late mortality are reported in Table 4. The de-
gree of aortic valve regurgitation at presentation was not
predictive of late mortality (P ¼ .145).
Reoperation on the aortic root or valve occurred in 20
(8.9%) of 225 patients who had survived the original
operation. The median interval to reoperation was 6.8
years (range, 0.2-20.3). Reoperations occurred in 6 pa-
tients (10.5%) in the composite valve conduit group, 8
(8.9%) in the root repair group (none in the remodeling
or reimplantation group), and 6 (7.7%) in the isolated
supracoronary replacement group (P ¼ .828). The2120 The Journal of Thoracic and Cardiovascular Surindications for reoperation included aortic root dilation
or valve regurgitation in 14 patients (70%), pseudoaneur-
ysm in 3 (15%), aortic valve infective endocarditis in 2
(10%), and paravalvular regurgitation in 1 (5%). Reoper-
ations included a composite valve conduit in 14 patients
(70%), aortic valve replacement in 4 (20%), and root
operation in 2 (10%).
Freedom from reoperation on the aortic root or valve at
10 and 20 years was 91.5%  2.3% and 79.3%  6.1%,
respectively (Figure 2). Freedom from reoperation on the
aortic root at 10 and 20 years was 93.4%  2.1% and
was 83.3%  5.8%, respectively. The freedom from reop-
eration on the aortic valve at 10 and 20 years was 92.3% 
2.2% and 81.8%  5.9%, respectively. No differences
were found among the groups with respect to freedom
from reoperation on the root or valve (P ¼ .605), root
(P ¼ .144), or valve (P ¼ .711). We identified no factors
that were predictive of reoperation on the aortic root or
valve.gery c November 2014
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in 6 patients (2.7%). The characteristics of the original
operation in this group included closed distal anastomosis
(ie, with aortic crossclamp in place) in 5 patients and
open hemiarch anastomosis in 1 patient. Also, 3 patients
were in the composite valve group, 2 in the isolated supra-
coronary group, and 1 in the root repair group. Freedom
from reoperation on the distal aorta or arch at 10 and 20
years was 97.2%  1.3%.
DISCUSSION
We report our 42-year experience with the operative
management of the aortic root in 269 patients treated with
primary sternotomy and surgery for acute ascending aorta
dissection. The overall operative mortality in our series re-
mained relatively constant at about 16% during the encom-
passing 4 decades. We found that aggressive aortic root
surgery does not affect the outcomes with respect to opera-
tive morbidity or morality or long-term survival or reopera-
tion on the aortic root or valve. Finally, patients undergoing
surgery for acute ascending aorta dissection experienced
reduced survival compared with age- and gender-matched
controls.
The choice of operation in the management of acute
ascending aorta dissection depends on many factors (eg,
root aneurysm, Marfan syndrome, dysfunctional aortic
valve). In the absence of these factors, it is unclear how
extensive should be the magnitude of the aortic root opera-
tion. For instance, Halstead and colleagues3 have recom-
mended an aggressive policy of composite valve conduit
placement in patients with acute ascending aorta dissection,
whereas Lai and colleagues4 have recommended a more
conservative procedure. Thus, difficulties exist in deter-
mining the best practice.
It is difficult to assess the magnitude of surgery by con-
structing groups of patients with similar preoperative char-
acteristics, because many factors determine the
aggressiveness or magnitude of the operation. For example,
a patient who presents with acute ascending aorta dissec-
tion, root dilation, and severe bicuspid aortic valve stenosis
will most likely undergo a different operation than a patient
who presents with isolated nondilated acute ascending aorta
dissection and a competent, nonstenotic aortic valve.
Recognizing the inherent differences in patient character-
istics, several investigators believe it is reasonable to study
patients according to the type of operation performed. The
foundation of this supposition has been that the outcome of
the operation will be most directly related to preventing
aorta rupture, correcting malperfusion and establishing
blood flow in the true aorta lumen, and establishing a
reasonably competent aortic valve, not necessarily on the
specific technique used to achieve the outcome. This philos-
ophy has been previously espoused by the groups from
Stanford, Yale, and Virginia.4-6The Journal of Thoracic and CarOur study has provided long-term outcome data support-
ing the premise, ‘‘the best operation is the one that has been
customized to each individual patient,’’ as so eloquently
stated by Lai and colleagues4 from the Stanford group. Sur-
vival will mostly be affected by patient-related factors, such
as was shown by our univariate and multivariate analyses.
Additional support comes from Ro and colleagues,7 who
noted that the maximal aortic root diameter at the initial pre-
sentation was the only significant predictor of postoperative
aortic regurgitation and aortic root dilatation, and Rylski
and colleagues,8 who reported that dissection of all 3 aortic
sinuses was the only predictor of reoperation.
Our study group had demographic data representative of
most series of patients undergoing surgery for acute
ascending aortic dissection. These included a mean age of
62 years and male gender for 67% of the patients. These
data are similar to those reported by Dell’Aquila and col-
leagues9 (319 patients; age, 63 years; 68% men), Geirsson
and colleagues10 (221 patients; age, 62 years; 66% men),
Rylski and colleagues8 (97 patients; age, 61 years; 67%
men), and others.4,11,12 With these data, we believe that a
comparison of our outcomes with those from previous
reports was reasonable.
We found no difference in the 30-day or in-hospital mor-
tality rates in the patients undergoing composite valve
conduit placement (14%), root repair (19%), or isolated
supracoronary ascending aorta replacement (14%;
P ¼ .485). These outcomes were similar to those recently
reported by Montalvo and colleagues,13 who noted an oper-
ative mortality of 7% in patients who had undergone an
aortic root operation and 11% in patients who had not (P
value reported as not significant, but a numeric value was
not given). Similar results have been reported by Halstead
and colleagues3 in 2005, Lai and colleagues4 in 2003, and
Moon and colleagues12 in 2001.
Other investigators, however, have reported worse opera-
tive mortality with more aggressive root surgery, most
notably Geirsson and colleagues10 from the University of
Pennsylvania group. They noted an operative mortality
rate of 23% in patients after composite root replacement
and 8% in patients who underwent surgery without a root
operation (P¼ .004). They were unable to provide an expla-
nation for the significant difference in mortality rates.10
They suggested that root replacement might be a marker
for more severe dissection and its associated increased oper-
ative time.10 However, no consensus has yet been reached
on this issue.
We have demonstrated no difference in long-term sur-
vival in our patients, whether they had undergone composite
valve conduit placement, root repair, or isolated supracoro-
nary ascending aorta replacement (P ¼ .098). These data
are corroborated by Geirsson and colleagues,10 who also
noted no difference in long-term survival (mean follow-
up, 49.1 months) after aortic valve suspension compareddiovascular Surgery c Volume 148, Number 5 2121
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(P ¼ .478); and Halstead and colleagues,3 who reported
no difference in survival between patients who had under-
gone received interposition graft replacement of the
ascending aorta (mean follow-up, 56.4 months) or compos-
ite graft replacement (mean follow-up, 65.8 months;
P ¼ .48). Other investigators have reported similar
results.4,11,12
We noted no difference in the freedom from reoperation
on the aortic root or valve among the composite valve
conduit, root repair, or isolated supracoronary ascending
aorta replacement groups. A similar, but somewhat contro-
versial, outcome has been reported by Halstead and col-
leagues.3 They stated, ‘‘There was a clear trend toward a
lower proximal reoperation rate after composite root
replacement.’’ However, the level of significance was
P ¼ .08. We disagree with their assessment and believe
that a P value of .08 does not represent a significant differ-
ence. Other groups have supported our conclusion,
including studies from The Netherlands,11 the University
of Pennsylvania,10 Stanford University,4 and Washington
University.12
We noted no improvement in operative mortality with
time, for which we have several potential explanations.
When we analyzed the 4 decade groups comparing patient
characteristics, the only difference with significance was
patient age. We found that the median patient age in each
group had increased significantly from the first to the last
decade by almost 20 years. Furthermore, our center is a
referral center, and some of our patients come by ambulance
from distant communities. The effect of the transport time
delay was unknown, and it could have negatively affected
our outcomes. Finally, although one would expect decline
in mortality over time, a level of operative mortality associ-
ated with repair of acute ascending aorta dissection might
be present that we just cannot improve on.
The most important limitation in our study was surgeon
bias in the choice of operation as that played out during
the 42-year study period. It was impossible to match pa-
tients according to preoperative characteristics, because
those characteristics are what most likely determine the
aggressiveness of the surgeon and the magnitude of the
operation. As an example, we reported a limited experience
with valve-sparing techniques (ie, 6 patients) and have not
included those techniques as a part of our routine practice
for patients with acute ascending aorta dissection. A bias
was present in the choice of operation that could not be
controlled for with reasonable certainty. Finally, it is
possible that some repeat operations were performed at
other facilities without our knowledge. This would have re-
sulted in an underreport of the repeat operation prevalence.2122 The Journal of Thoracic and Cardiovascular SurHowever, such a bias would theoretically have applied to all
3 operative study cohorts.
CONCLUSIONS
Acute ascending aorta dissection is a challenging condi-
tion to treat, and the associated operative morbidity and
mortality is significant. Most factors that affect the opera-
tive outcomes are patient related. Understanding that rela-
tionship, surgeons must be cautious not to over- or
undertreat these patients. The key will be to customize the
operation to the individual patient (ie, let the pathologic
findings dictate the operative procedure). To the best of
our knowledge, durable 20-year outcomes can result.
Regardless of the repair type, patients undergoing surgery
for acute ascending aorta dissection will experience
reduced survival compared with age- and gender-matched
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